So, it appears that it is official that Delzicol is replacing Asacol, as it is bioequivalent.
http://www.ashp.org/DrugShorta...ulletin.aspx?id=1017
So, it is not as if there will be no treatment available. I agree though, that it seems to be sort of an "end run" to avoid losing market share.
http://www.istockanalyst.com/f...-of-potential-upside
Jan